subject area of
- Adherence to guidelines in the use of biological agents to treat psoriasis in Brazil Academic Article
- Availability of legalized cannabis reduces demand for illegal cannabis among Canadian cannabis users: evidence from a behavioural economic substitution paradigm Academic Article
- Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice Academic Article
- Canada’s laws on pharmaceutical intellectual property: the case for fundamental reform: Figure 1: Academic Article
- Cannabis use and misuse in the year following recreational cannabis legalization in Canada: A longitudinal observational cohort study of community adults in Ontario Academic Article
- Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada Academic Article
- Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements? Academic Article
- Is the GAIN Act a turning point in new antibiotic discovery? Academic Article
- Medical marijuana: can we think about it? Academic Article
- New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit? Academic Article
- Reimagining Research with Pregnant Women and Parents Who Consume Cannabis in the Era of Legalization: The Value of Integrating Intersectional Feminist and Participatory Action Approaches Academic Article
- Something old, something new: revisiting natural products in antibiotic drug discovery Academic Article
- US Medicare reform: why drug companies and private insurers are smiling. Academic Article